Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-31 @ 12:06 PM
Study NCT ID:
NCT07392320
Status:
RECRUITING
Last Update Posted:
2026-02-06
First Post:
2026-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-02-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2031-02-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-02-04
Completion Date Type:
ESTIMATED
First Submit Date:
2026-01-26
First Submit QC Date:
None
Study First Post Date:
2026-02-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-02
Last Update Post Date:
2026-02-06
Last Update Post Date Type:
ACTUAL